Aging is associated with a substantial decline in immune function that manifests as increased incidence of infection and malignancy and decreased responsiveness to vaccination 1,2 . Given the worldwide demographic shift toward older populations 3 , it is essential to understand mechanisms involved with age-related decline of immunity and identify strategies for restoring immune function. Published studies suggest causative links between immunosenescence, metabolism and aging and reveal that the age-associated decline in immune function may be partially reversible [4] [5] [6] [7] [8] MAPKs are signal-transducing enzymes involved in diverse aspects of mammalian physiology, including senescence, aging and metabolism 11 . Three main subgroups of MAPKs have been identified: Erk, Jnk and p38 (ref. 12). Given the broad functions they control and the existence of independent upstream activation cascades, it is thought that each MAPK subgroup is separately regulated within individual cells [12] [13] [14] . The possibility that all three MAPK subgroups may be coordinately controlled within a single cell type has remained unexplored.
Aging is associated with a substantial decline in immune function that manifests as increased incidence of infection and malignancy and decreased responsiveness to vaccination 1, 2 . Given the worldwide demographic shift toward older populations 3 , it is essential to understand mechanisms involved with age-related decline of immunity and identify strategies for restoring immune function. Published studies suggest causative links between immunosenescence, metabolism and aging and reveal that the age-associated decline in immune function may be partially reversible [4] [5] [6] [7] [8] . However, how the myriad of functional defects simultaneously appear in individual aged cells remains largely unknown.
Human T cells showing multiple features of senescence increase in number during aging 9 . There is a sequential loss of the costimulatory receptors CD27 and CD28 as T cells progress toward senescence 10 . Early-stage T cells within the CD4 compartment are CD27 + CD28 + , those at an intermediate stage are CD27 − CD28 + , and senescent T cells are CD27 − CD28 − (ref. 5) .
MAPKs are signal-transducing enzymes involved in diverse aspects of mammalian physiology, including senescence, aging and metabolism 11 . Three main subgroups of MAPKs have been identified: Erk, Jnk and p38 (ref. 12) . Given the broad functions they control and the existence of independent upstream activation cascades, it is thought that each MAPK subgroup is separately regulated within individual cells [12] [13] [14] . The possibility that all three MAPK subgroups may be coordinately controlled within a single cell type has remained unexplored.
Sestrins, the mammalian products of the Sesn1, Sesn2 and Sesn3 genes [15] [16] [17] , are poorly understood stress-sensing proteins that lack obvious catalytic domains and stimulate the activation of AMPK by an unknown mechanism while inhibiting mammalian target of rapamycin complex 1 (mTORC1) signaling 18 . AMPK is a heterotrimeric protein consisting of the catalytic α-subunit and the regulatory β-and γ-subunits that are activated in response to increased intracellular AMP/ATP ratio 19 . Sestrins have been proposed to inhibit mTORC1 signaling through both AMPK-dependent and independent pathways that involve formation of a complex with the Rag GTPases 18, [20] [21] [22] [23] [24] [25] . Owing to their mTORC1 inhibitory activity, various anti-aging functions have been ascribed to both the mammalian sestrins and their Drosophila counterpart, dSesn 20 . However, whether sestrins have a role in the control of the immune response has not been determined.
In this study, we found that sestrins have pro-aging activities in T lymphocytes. We identified a sestrin-dependent MAPK activation complex (termed sMAC), in which sestrins simultaneously coordinate the activation of Erk, Jnk and p38 in these cells. We found that each MAPK, once activated, controls a unique functional response. Disruption of the sMAC restored antigen-specific proliferation and cytokine production in T cells from old humans and enhanced responsiveness to influenza vaccination in old mice.
RESULTS

Sestrins are broad regulators of T cell senescence
The sestrins have anti-aging properties in muscle 20 , but their functions in the immune system have not been studied. We examined the expression of sestrin 1, sestrin 2 and sestrin 3 proteins in blood-derived primary human CD4 + T cells from young donors (<40 years old) defined as nonsenescent (CD27 + CD28 + ), intermediate (CD27 − CD28 + ) or senescent (CD27 − CD28 − ) CD4 + T cells as described 5 . CD27 − CD28 − CD4 + T cells expressed significantly higher amounts of sestrin 1, sestrin 2 and sestrin 3 than CD27 + CD28 + CD4 + or CD27 − CD28 + CD4 + T cells (Fig. 1a,b) . We probed the function of endogenous sestrin proteins by transducing activated CD27 − CD28 − CD4 + T cells with lentiviral vectors coexpressing a GFP reporter and inhibitory small hairpin RNAs (shRNAs) targeting SESN1 (shSesn1), SESN2 (shSesn2) or SESN3 (shSesn3). A nonsilencing shRNA lentiviral vector was used as a control (shCtrl) (Supplementary Fig. 1a-c) . Compared to shCtrl-transduced controls, CD27 − CD28 − T cells transduced with shSesn1, shSesn2 or shSesn3 showed broad functional reversal of senescence, apparent as enhancement of cell proliferation (Fig. 1c) and telomerase activity (Fig. 1d) , fewer DNA damage foci (Fig. 1e) and re-expression of the TCR signalosome components Lck and Zap70 (Fig. 1f and data not shown) and the costimulatory receptors CD27 and CD28 (Fig. 1g) . This enhancement of functionality in CD27 − CD28 − CD4 + T cells was accompanied by restored calcium flux (Fig. 1h) and IL-2 synthesis (Fig. 1i) . Therefore, in contrast to their well-documented anti-aging properties in invertebrates 20, 26 , the sestrins induced multiple characteristics of senescence in T cells.
Sestrins bind and activate MAPKs in CD27 − CD28 − CD4 + T cells In Drosophila, mouse liver homogenates and human embryonic kidney (HEK293) cells, sestrin function, including the anti-aging A r t i c l e s effects, is largely mTORC1 dependent 20, 21, [23] [24] [25] 27, 28 . We found that CD27 − CD28 − CD4 + T cells lacked expression of both the kinase mTOR and its downstream effector kinase S6K1 (Supplementary Fig. 1d) . Transduction of shSesn1, shSesn2 or shSesn3 in CD27 − CD28 − CD4 + T cells restored both mTOR expression and downstream S6K1 activation (Supplementary Fig. 1e ). However, these cells maintained significantly (P < 0.01, ANOVA for repeated measures with a Bonferroni post-test correction) higher calcium flux (Supplementary Fig. 1f) , interleukin 2 (IL-2) synthesis (Supplementary Fig. 1g ), telomerase activity (Supplementary Fig. 1h ) and clearance of DNA damage foci (Supplementary Fig. 1i ) than that of shCtrl-transduced cells, even in the presence of the mTOR inhibitor rapamycin. This indicates an mTORC1-independent mechanism of sestrin action.
To identify pro-senescence pathways of sestrin action, we immunoprecipitated sestrin 1 from blood-derived, unstimulated CD27 − CD28 − CD4 + T cells using an irrelevant IgG antibody as a control. Compared to IgG immunoprecipitates, sestrin 1 immunoprecipitates were enriched for phosphorylated Erk, Jnk and p38 MAPKs 12 ( Fig. 2a) . Phosphorylated AMPK also precipitated with sestrin 1 (Fig. 2a) . Similarly, sestrin 2 coimmunoprecipitated with phosphorylated Erk, Jnk and p38 in CD27 − CD28 − CD4 + T cells (Supplementary Fig. 2a ). This suggests the presence of an endogenous supramolecular sMAC composed of sestrins and phosphorylated AMPK and Erk and Jnk and p38 MAPKs.
Next we measured spontaneous Erk, Jnk and p38 MAPK activation in blood-derived CD27 + CD28 + , CD27 − CD28 + and CD27 − CD28 − T cells within the CD4 + subset. Endogenous MAPK activation was enhanced in CD27 − CD28 − T cells compared to CD27 + CD28 + or CD27 − CD28 + T cell subsets (Supplementary Fig. 2b ). To investigate canonical MAPK activators, we probed lysates from CD27 + CD28 + , CD27 − CD28 + and CD27 − CD28 − CD4 + T cell subsets directly ex vivo with antibodies to MKK7 (activator of Jnk), MKK4 (activator of Jnk and/or p38) and phosphorylated MEKK1 and MEKK2 (activators of Erk). CD27 − CD28 − T cells did not express or endogenously activate any upstream MKK4, MKK7 or MEKK1 and MEKK2 molecules (Supplementary Fig. 2c ). We next transfected small interfering RNAs (siRNAs) targeting MEKK1, MKK7 and MKK4 in CD27 + CD28 + CD4 + and CD27 − CD28 − CD4 + T cell subsets and measured Erk, Jnk and p38 phosphorylation in both cell types by phospho-flow technology. A scrambled siRNA was used as control ( Supplementary  Fig. 2d ). Compared to control transfection, siRNAs against MEKK1, MKK7 and MKK4 inhibited Erk, Jnk and p38 phosphorylation in CD27 + CD28 + CD4 + T cells, respectively. In contrast, Erk, Jnk and p38 phosphorylation were not affected in CD27 − CD28 − CD4 + T cells (Supplementary Fig. 2e ). Thus, endogenous MAPK phosphorylation in CD27 − CD28 − T cells takes place in the absence of upstream canonical MAPK signaling 11 .
We next investigated whether sestrins are noncanonical regulators of MAPK function. In vitro kinase assays demonstrated disrupted MAPK phosphorylation in AMPK immunoprecipitates from CD27 − CD28 − CD4 + T cells transduced with shRNAs against sestrins 1-3 (triple-knockdown cells) compared to those transduced with shCtrl (Fig. 2b) . However, treatment of triple-knockdown T cells with the selective AMPK agonist A-769662 (ref. 29 ) for 1 h reconstituted MAPK activation to levels detected with shCtrl transduction (Fig. 2b) . We then transduced shAMPK 5 and shCtrl vectors in CD27 − CD28 − CD4 + T cells, immunoprecipitated sestrin 2 and performed in vitro MAPK assays. MAPK phosphorylation was reduced in sestrin 2 immunoprecipitates from shAMPK-transduced CD27 − CD28 − CD4 + T cells compared to shCtrl-transduced cells (Supplementary Fig. 2f ). Thus, sestrins promote MAPK activation via AMPK.
Because the dual phosphorylation site of MAPK proteins (a Thr-Xaa-Tyr motif within the activation loop) is not a direct AMPK substrate 5 , we investigated whether sestrin-bound MAPKs undergo AMPK-dependent autophosphorylation. Adding exogenous ATP to sestrin 1 immunoprecipitates from CD27 − CD28 − CD4 + T cells strongly enhanced MAPK phosphorylation in response to incubation with A-769662 compared to unstimulated reactions (Fig. 2c) . The ATP-competitive Erk inhibitor FR18024, the Jnk inhibitor SP-600125 and the p38 inhibitor SB-203580 each impeded AMPK agonist-driven MAPK phosphorylation (Fig. 2c) . Thus, individual MAPK activities are required for sMAC activation. Furthermore, MAPK autophosphorylation is triggered by activation of AMPK. We next tested whether sestrins modulate MAPK signaling by promoting ATP removal from the γ subunit of AMPK 28 . We therefore transduced CD27 − CD28 − CD4 + T cells with the sestrin-specific shRNAs individually and together, then immunoprecipitated AMPK-γ and measured ATP content by ELISA. The ATP contents in AMPK-γ immunoprecipitates from CD27 − CD28 − CD4 + T cells increased alongside progressive single, dual or triple silencing of sestrin proteins (Fig. 2d) . Similarly, phosphorylation of AMPK-α, the catalytic subunit of the enzyme, was inhibited in extracts from triple-knockdown CD27 − CD28 − CD4 + T cells compared to shCtrl transduction (Fig. 2e) . In addition, when we transfected CD27 − CD28 − CD4 + T cells with siRNA targeting AMPK-γ ( Supplementary Fig. 2f ) and immunoprecipitated sestrin 1, we found lower Erk, Jnk and p38 MAPK expression in the sestrin 1 complex, as compared to cells transfected with control siRNA (siCtrl) (Fig. 2f) . Thus, sestrins regulate Erk, Jnk and p38 MAPK autophosphorylation by fine-tuning AMPK-γ ATP loading.
Recombinant sestrins reconstitute sMAC
We performed in vitro reconstitution experiments using lysates from CD27 + CD28 + CD4 + T cells, which do not express endogenous sestrin proteins. We transfected siAMPK-γ or siCtrl into CD27 + CD28 + T cells that were lysed and immunoprecipitated with antibodies to AMPK-α 36 h later. We then added either recombinant sestrins 1, 2 and/or 3 or GFP proteins and measured Erk, Jnk and p38 phosphorylation. The addition of sestrins triggered dosedependent activation of AMPK-associated MAPKs in lysates from siCtrl-transfected CD27 + CD28 + CD4 + T cells compared to recombinant GFP protein (Fig. 3a) . In contrast, siAMPK-γ transfection in CD27 + CD28 + CD4 + T cells prevented sestrin-driven MAPK activation (Fig. 3a) . MAPK recruitment to AMPK was not significantly altered by recombinant sestrins in these in vitro reconstitution assays (Fig. 3b) . These data suggest that sestrins coordinate the sMAC upstream of AMPK-γ and that all MAPKs are bound to AMPK in their inactive form.
To study whether the sMAC formed as a unique complex, we added sestrins 1-3 to lysates of blood-derived primary human CD27 + CD28 + CD4 + T cells then analyzed sestrin 2 immunoprecipitates using gel-filtration chromatography. Under native conditions, the sMAC eluted with an estimated molecular mass of ~1,000 kDa (Fig. 3c) , whereas the sestrin-mTORC1 inhibitory complex, which contains GATOR2 and RagA and RagB [23] [24] [25] , was 660 kDa (Fig. 3c) . Endogenous complexes of similar size were eluted from lysates obtained from CD27 + CD28 + CD4 + T cells that had been glucose starved for 12 h (ref. 5) and immunoprecipitated with sestrin 2 (data not shown), indicating that physiological stress stimuli also triggered the formation of two sestrin-containing complexes of different sizes, controlling either mTORC1 or MAPK activities in primary human CD27 + CD28 + CD4 + T cells.
To determine the physiological impact of endogenous sMAC formation in CD27 + CD28 + CD4 + T cells, we transduced these cells either with shSesn1, shSesn2 and shSesn3 or with shCtrl lentiviral vectors and exposed them to irradiation to induce a stress response. Sestrin expression was upregulated in CD27 + CD28 + T cells after irradiation (Supplementary Fig. 3a) . Notably, phosphorylation of Erk, Jnk and p38 was strongly induced upon irradiation of shCtrl-transduced CD27 + CD28 + CD4 + T cells compared to triple-knockdown CD27 + CD28 + CD4 + T cells (Fig. 3d) . Notably, triple knockdown of sestrin in irradiated CD27 + CD28 + CD4 + T cells preserved telomerase activity (Supplementary Fig. 3b ) and IL-2 production (Supplementary Fig. 3c ). Sestrin-knockdown CD27 + CD28 + T cells also showed lower irradiation-triggered DNA damage (Supplementary Fig. 3d ), indicating that sestrin expression is required for induction of senescence in stressed T cells.
Each MAPK controls distinct aspects of T cell senescence
Because all three MAPKs were activated in the sMAC after AMPK activation, we investigated the role of each MAPK in this complex. We treated CD27 − CD28 − CD4 + T cells with MAPK inhibitor (MAPKi) FR18024 (an Erk inhibitor), SP-600125 (a Jnk inhibitor) or SB-203580 (a p38 inhibitor) for 36 h before immunoprecipitating sestrin 1 and measuring Erk, Jnk and p38 phosphorylation. Endogenous MAPK phosphorylation of sestrin 1-associated MAPKs was inhibited in MAPKi-treated CD27 − CD28 − CD4 + T cells but not in cells treated with DMSO (Supplementary Fig. 4a ). In these experiments, blocking any MAPK increased CD3-and recombinant human IL-2 (rhIL-2)-induced proliferation of CD27 − CD28 − CD4 + T cells by 2-to 2.5-fold, as compared to cells treated with DMSO vehicle (Supplementary Fig. 4b ). 
A r t i c l e s
However, inhibition of p38, but not of Jnk or Erk, enhanced telomerase activity in CD3-and rhIL-2-activated CD27 − CD28 − CD4 + T cells compared to DMSO (Fig. 4a) , as previously reported 4, 5, 30 . Conversely, blocking Erk but not p38 or Jnk activation decreased endogenous DNA damage foci in CD3-and rhIL-2-activated CD27 − CD28 − CD4 + T cells (Fig. 4b) . Finally, blocking activation of Jnk, but not of p38 or Erk, restored expression of the key TCR signalosome component Lck in CD27 − CD28 − CD4 + T cells (Fig. 4c) and of the costimulatory receptor CD28 (data not shown). Similar results were obtained in CD27 − CD28 − CD4 + T cells after siRNA-mediated silencing of Jnk, Erk or p38 (Supplementary Fig. 4c,d) . Thus, MAPK activation promotes T cell senescence, but each MAPK regulates unique functional hallmarks of the senescence program.
We incubated shSesn2-transduced CD27 − CD28 − CD4 + T cells with the AMPK agonist A-769662, which activates AMPK independently of sestrins (Supplementary Fig. 4e ) followed by treatment with siRNAs specific for Erk, p38 or Jnk for 48 h. Compared to controls, shSesn2-transduction in CD27 − CD28 − CD4 + T cells led to enhanced telomerase activity (Fig. 4d) and T cell activation (as measured by increased calcium flux) (Fig. 4e) and decreased formation of DNA damage foci (Fig. 4f) . However, agonist-induced activation of AMPK reversed these functional changes (Fig. 4d-f) , suggesting that the sestrins act via AMPK to inhibit functional responses in CD27 − CD28 − CD4 + T cells. Notably, transfection of siRNA against p38, Jnk or Erk in AMPK agonist-treated, shSesn2-transduced CD27 − CD28 − CD4 + T cells restored telomerase activity (sip38) and TCR activation (siJnk) and reduced DNA damage foci (siErk) (Fig. 4d-f) . Similar observations were made when silencing sestrin 1 in CD27 − CD28 − CD4 + T cells (Supplementary Fig. 4f) . Thus, each MAPK in the sMAC controlled different aspects of T cell senescence downstream of a common sestrin trigger.
Enhanced sMAC formation with age
We investigated whether the sestrins 'preferentially' modulate T cell function in older humans. We found up to a tenfold increase in sestrin expression in total CD4 + T cells from older humans (age 70-85 years) compared to younger ones (age 20-35 years) (Fig. 5a) . Sestrin 2 expression was highest in CD27 − CD28 − CD4 + T cells from older individuals (Fig. 5b) . We did not detect sMAC in CD27 + CD28 + CD4 + T cells from younger individuals by ImageStream analysis (Fig. 5c) , whereas sestrin 2 colocalized with phosphorylated Erk, Jnk and p38 in CD27 − CD28 − CD4 + T cells isolated from the same subjects (Fig. 5c) . In contrast, CD27 − CD28 − and, to a lesser extent, CD27 + CD28 + CD4 + T cells from older humans showed colocalization of sestrin 2 and phosphorylated MAPKs (Fig. 5c) . Single-cell analysis of colocalization scores of sestrin 2 and phosphorylated MAPKs showed an age-dependent increase in sMAC formation (Fig. 5d) . This identifies enhanced formation of the sMAC in human T cells during aging. Shingles is caused by the reactivation of varicella zoster virus (VZV), and the incidence of this disease increases with age 31, 32 . In both young (20-35 years old) and old (70-85 years old) individuals, the CD27 + CD28 + CD4 + T cells showed higher proliferative activity in response to VZV antigen activation than the CD27 − CD28 − CD4 + T cell population (Fig. 5e) . In addition, the proliferation of both subsets was lower in old than in young individuals (Fig. 5e) . shRNAmediated silencing of sestrin 1 in CD27 − CD28 − CD4 + T cells from old donors significantly enhanced their proliferation (Fig. 5f ) and IL-2 synthesis (Fig. 5g) after VZV activation compared to shCtrl transduction, especially at low antigen doses and when transducing shSesn2 and shSesn3 in addition to shSesn1 (Fig. 5f,g ). Similar results were obtained with cytomegalovirus (CMV)-specific T cell responses from old humans (Supplementary Fig. 5a,b) . Therefore, silencing of sestrin expression in primary T cell populations from old humans enhanced antigen-specific proliferation and cytokine production in vitro.
Sestrin deficiency enhances vaccine response in old mice CD4 + T cells from 20-month-old mice showed higher expression of sestrin 1, sestrin 2 and sestrin 3 than those from young (2-monthold) mice (Supplementary Fig. 6a) . We investigated the response to influenza vaccination in age-matched Sesn1 +/− and Sesn1 −/− mice. Sesn1 −/− mice did not express sestrin 1 (Supplementary Fig. 6b ). Mice were housed together for 20 months and challenged subcutaneously with FLUAD, a clinically approved trivalent inactivated influenza human vaccine that is also effective in rodents 33 . Saline injection served as a control. Five days after vaccination, Sesn1 −/− but not Sesn1 +/− mice showed splenomegaly (Supplementary Fig. 6c ) and a threefold increase in splenocytes (Fig. 6a) . Correspondingly, we observed a twofold increase in the frequencies of splenic CD4 + and CD8 + T cells in vaccinated Sesn1 −/− mice, as compared to vaccinated Sesn1 +/− mice ( Fig. 6b and Supplementary Fig. 6d ). The frequencies of myeloid and natural killer (NK) cells were also fivefold and twofold higher, respectively, in vaccinated Sesn1 −/− mice than in controls (Supplementary Fig. 6e,f) . Within the CD4 + T cell compartment, we observed a twofold expansion of CD62L − CD44 + T effector cells and a corresponding contraction of the CD62L + CD44 − naive T cell population from vaccinated Sesn1 −/− mice, as compared to vaccinated 
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Sesn1 +/− controls ( Fig. 6c and Supplementary Fig. 6g ). These differences in T cell frequencies between genotypes were not evident before vaccination (data not shown). Functionally, Sesn1 −/− CD4 + T cells showed higher IL-2 and IFN-γ production and enhanced proliferation than Sesn1 +/− mice after vaccination (Fig. 6d,e) . Therefore, sestrin deficiency enhances T cell responsiveness and expansion of innate cells during aging in vivo.
To investigate whether enhanced T cell responsiveness after vaccination was antigen specific, we re-challenged Sesn1 +/− and Sesn1 −/− T cells with Sesn1 +/− antigen-presenting cells (APCs) pulsed with FLUAD in vitro. We observed higher IFN-γ and IL-2 expression in Sesn1 −/− than in Sesn1 +/− CD4 + T cells (Fig. 6f and data not shown) . In addition, siRNA-mediated silencing of sestrin 2 in Sesn1 −/− CD4 + T cells further increased their responsiveness to Sesn1 +/− APCs pulsed with FLUAD (Fig. 6f) .
When measuring antibody titers, we found a two-to threefold increase in influenza-specific circulating IgGs in Sesn1 −/− mice, compared to Sesn1 +/− mice (Fig. 6g) and Sesn1 −/− B cells showed enhanced IgG isotypic switching compared to Sesn1 +/− mice after vaccination (Supplementary Fig. 6h) . B cell frequencies, however, were slightly lower in the spleens of vaccinated Sesn1 −/− mice than in those of vaccinated Sesn1 +/− mice (data not shown). Vaccination increased the numbers of T cells, NK and myeloid cells and IgG + B cells in Sesn1 −/− mice, as compared to unvaccinated Sesn1 −/− mice (Supplementary Fig. 6i) . Thus, sestrin deficiency restores vaccine responsiveness during aging in vivo.
MAPK inhibition phenocopies sestrin deficiency in vivo
We next measured Erk, Jnk and p38 phosphorylation in sestrin 2 + CD4 + T cells, which made up as much as 70% of the total CD4 + T cell pool (Fig. 7a) in 20-month-old Sesn1 +/− and Sesn1 −/− mice after FLUAD vaccination. Erk, Jnk and p38 phosphorylation was robust in sestrin 2 + CD4 + T cells from Sesn1 +/− mice and was low in Sesn1 −/− CD4 + T cells (Fig. 7b) . Notably, disruption of Erk, Jnk and p38 phosphorylation was correlated with higher IFN-γ production in sestrin 2 + CD4 + T cells from vaccinated Sesn1 −/− mice than in Sesn1 +/− mice (Fig. 7c) . Sestrin 1 deficiency did not inhibit Erk, Jnk or p38 phosphorylation in the minor sestrin 2 − CD4 + T cells compared to those from Sesn1 +/− mice (Supplementary Fig. 7a ). To test whether inhibition of all MAPKs would boost vaccine responsiveness in aged mice, we administered the Erk inhibitor FR18024, the Jnk inhibitor SP-600125 and/or the p38 inhibitor SB-203580 by intraperitoneal injection in 16-month-old mice vaccinated with FLUAD and examined both the sestrin 2 + CD4 + T cell and CD19 + B cell subsets. Mice treated with all three MAPK inhibitors developed splenomegaly (Fig. 7d and Supplementary  Fig. 7b ) and showed higher splenic CD4 + T cell numbers than did DMSO vehicle-treated controls or mice receiving only one MAPK inhibitor after vaccination (Fig. 7e) . MAPK self-phosphorylation was either selectively or globally inhibited in CD4 + T cells from mice treated with one or all three MAPK inhibitors, respectively, as compared to mice treated with DMSO (Fig. 7f) . Compared to DMSO treatment, triple (but not single) inhibition of MAPKs boosted IFN-γ synthesis in sestrin 2 + CD4 + T cells after vaccination (Fig. 7g) . Triple MAPK inhibition also induced a threefold increase in the frequencies of sestrin 2 + CD19 + B cells undergoing vaccine-specific IgG isotypic switch, which was not observed with inhibition of individual MAPKs (Fig. 7g) . In contrast, inhibition of MAPK signaling in both sestrin 2 − CD4 + T and CD19 + B cells reduced vaccine-induced IFN-γ production and IgG isotype switching, respectively (Supplementary Fig. 7c) . Thus, disruption of all MAPK pathways in sestrin 2 + T and B cell populations enhanced vaccine responsiveness in old mice.
The sMAC is formed in mouse T cells We isolated CD4 + T cells from Sesn1 +/− and Sesn1 −/− mice, immunoprecipitated sestrin 2, and investigated Erk, Jnk and p38 phosphorylation. Sestrin 2 complexes from Sesn1 −/− CD4 + T cells showed lower phosphorylation of Erk, Jnk and p38 than those from Sesn1 +/− CD4 + T cells (Fig. 8a,b) . Sestrin 2-MAPK binding was not affected by sestrin 1 deficiency (data not shown). ImageStream analysis confirmed disrupted sMAC activation in spleen-derived CD4 + T cells from Sesn1 −/− mice compared to Sesn1 +/− mice (Fig. 8c,d) . In vitro kinase assays showed that incubation of sestrin 2 immunoprecipitates from Sesn1 −/− mouse CD4 + T cells with recombinant human sestrin 1 restored MAPK activation in lysates from these cells (Fig. 8e) . This effect was not observed in sestrin 2 immunoprecipitates from CD4 + T cells treated with siAMPK-γ (Fig. 8e) . A-769662 agonist-driven activation of AMPK also restored MAPK phosphorylation in sestrin 2 immunoprecipitates from splenic Sesn1 −/− CD4 + T cells and was further enhanced by the addition of ATP, which is needed to fuel MAPK autophosphorylation (Fig. 8f) . Thus, the sMAC is formed and coordinated by the sestrins in mice.
DISCUSSION
Here we show that in CD27 − CD28 − CD4 + T cells Erk, Jnk and p38 MAPK are simultaneously activated owing to constitutive expression of sestrin proteins. In flies, sestrin expression increases on maturation and aging and triggers feedback anti-aging pathways through a TORC1 inhibitory complex 20 . Similarly, in muscle, sestrins exhibit mTORC1-dependent anti-aging activities 22 . We now describe an opposite pro-aging function of sestrins in T cells that occurs independently of mTORC1 and instead is mediated by an Erk-Jnk-p38 activation complex, termed sMAC. Such coordinated MAPK activation was previously unknown and is distinct from the canonical MAPK activation cascades where Erk, Jnk and p38 are regulated independently 11 . All regulatory elements within the sMAC interacted constitutively in CD27 − CD28 − CD4 + T cells. The sMAC was also distinct from the previously described sestrin-mTORC1 inhibitory complexes containing GATOR and RAG proteins [23] [24] [25] , suggesting that the anti-agingpro-aging dichotomy of sestrin action in T cells versus other cell types may depend on different sestrin-protein interactions. Consistently, mTORC1 inhibition has been strongly associated with longevity in both murine muscle and in insects 34 , and p38 MAPK activation can drive T cell aging and senescence [4] [5] [6] 30 . Sestrin may therefore exert anti-or pro-aging effects through different macromolecular complexes. Whether the sMAC also controls aging in nonimmune cells remains to be determined.
The sMAC also formed in CD27 + CD28 + T cells upon glucose deprivation (data not shown), and this extends previous observations highlighting the convergence of senescence and low-nutrient signals to regulate T cell function ('intra-sensory' signaling) 5, 9 . When examining glucose-deprived sestrin-silenced CD27 + CD28 + T cells, we also found disruption of AMPK phosphorylation and a transient A r t i c l e s increase in T cell activation followed by T cell death when glucose deprivation persisted (data not shown). Sestrins may thus function as energy-sensing 'rheostats' that directly bind AMPK-γ and promote AMPK activation to favor T cell survival at the expenses of function under severe stress.
The sMAC was larger than the sestrin-mTORC1 inhibitory complex, and additional proteins may contribute to its regulation. p38 autophosphorylation is a feature of noncanonical MAPK activation in T cells that requires p38 binding to specific scaffolding molecules such as TAB1 (refs. 5,35) . We now show that sMAC coordinates the simultaneous activation of all MAPK pathways. However, TAB1 was not required for the activation of Jnk or Erk, but it mediated activation of p38 within the sMAC (data not shown). We propose a model in which three separate MAPK subcomplexes are constitutively bound to AMPK in their inactive forms. When expressed, sestrins promote the unloading of ATP from AMPK-γ and activate the AMPK complex. In turn, this triggers the autophosphorylation of all associated MAPKs. Distinct scaffolding molecules may be required to support the autophosphorylation of each of the three MAPKs in the sMAC.
Silencing of sestrin expression allowed a broad enhancement of T cell activity, whereas downstream targeting of any individual MAPK was much more selective. It is therefore possible to exert narrower or broader control over senescence-related T cell functional changes by targeting different molecules within the sMAC. As each MAPK controls different aspects of T cell senescence, they may have to be targeted simultaneously for effective immune boosting during aging. However, direct inhibition of MAPKs may not be feasible for immunotherapy, as it would negatively regulate the responses of T and B lymphocytes that do not express sestrins. In contrast, inhibition of the sestrins would disrupt global MAPK signaling. This would spare sestrin-negative cells in which MAPKs may be activated via canonical pathways 36 and may thus circumvent toxicity. A possible caveat is that sestrin inhibition may enhance the proliferative activity of senescent cells that have residual DNA damage and, therefore, prolonged inhibition of sestrins may result in malignancy 37 . However, short-term inhibition of sestrins could be a beneficial immunotherapeutic strategy.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
